hydroxychloroquine

Patients with lupus with COVID-19: University of Michigan experience
Beth Wallace, Laraine Washer, Wendy Marder, J Michelle Kahlenberg

Annals of the Rheumatic Diseases May 2020, annrheumdis-2020-217794; DOI: 10.1136/annrheumdis-2020-217794
Response to: ‘Patients with lupus with COVID-19: University of Michigan experience’ by Wallace et al
Alexis Mathian, Zahir Amoura

Annals of the Rheumatic Diseases May 2020, annrheumdis-2020-217910; DOI: 10.1136/annrheumdis-2020-217910
Correspondence regarding research letter to the editor by Mathian et al, ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’
Mandana Nikpour, Benjamin Teh, Ian P Wicks, Marc Pellegrini

Annals of the Rheumatic Diseases May 2020, annrheumdis-2020-217827; DOI: 10.1136/annrheumdis-2020-217827
Response to: Correspondence regarding research letter to the editor by Mathian et al, ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’’ by Nikpour et al
Alexis Mathian, Zahir Amoura

Annals of the Rheumatic Diseases May 2020, annrheumdis-2020-217875; DOI: 10.1136/annrheumdis-2020-217875
Response to: ‘Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?’ by Erre et al
Elizabeth R Graef, Jean W Liew, Alfred HJ Kim, Jeffrey A Sparks

Annals of the Rheumatic Diseases May 2020, annrheumdis-2020-217923; DOI: 10.1136/annrheumdis-2020-217923
Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?
Gian Luca Erre, Edoardo Sean Ferraccioli, Matteo Piga, Arduino Mangoni, Giuseppe Passiu, Elisa Gremese, Gianfranco Ferraccioli

Annals of the Rheumatic Diseases May 2020, annrheumdis-2020-217828; DOI: 10.1136/annrheumdis-2020-217828
Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus
Chia-Ying Wu, Magdalene Tan, Jing-Yang Huang, Jeng-Yuan Chiou, James Cheng-Chung Wei

Annals of the Rheumatic Diseases May 2020, annrheumdis-2020-217728; DOI: 10.1136/annrheumdis-2020-217728
Response to: ‘Hydroxychloroquine shortages during the COVID-19 pandemic’ by Mendel et al
Iain McInnes

Annals of the Rheumatic Diseases May 2020, annrheumdis-2020-217954; DOI: 10.1136/annrheumdis-2020-217954
Response to: ‘Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus’ by Wu et al
Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas

Annals of the Rheumatic Diseases May 2020, annrheumdis-2020-217804; DOI: 10.1136/annrheumdis-2020-217804
Hydroxychloroquine shortages during the COVID-19 pandemic
Arielle Mendel, Sasha Bernatsky, J Carter Thorne, Diane Lacaille, Sindhu R Johnson, Évelyne Vinet

Annals of the Rheumatic Diseases May 2020, annrheumdis-2020-217835; DOI: 10.1136/annrheumdis-2020-217835

Main menu

hydroxychloroquine

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

hydroxychloroquine

Pages